IN THE NEWS

CathVision

CathVision adds U.S. profile to its Board of Directors

March 16, 2021

CathVision ApS, a medical device company developing a novel artificial intelligence therapeutic platform for cardiac electrophysiology procedures, is announcing a change to its Board of Directors.

Cathvision presents clinical results of first in human study at AF Symposium conference

Jan 29, 2021

CathVision ApS,  a medical device company developing a novel cardiac electrophysiology system and artificial intelligence platform to guide ablation therapy for heart rhythm disorders, is featured at the 26thannual international AF Symposium, held online January 29-31st

Cathvision Completes New Investment Round of a Total 13M Euro

May 19, 2020

CathVision ApS, a medical device company developing a novel artificial intelligence therapeutic platform for cardiac electrophysiology procedures, has completed an investment round of a total 13M euro. Both existing and new investors participated in the round. The proceeds allow the company to begin multi-center clinical studies and complete its FDA approval process for the CathVision Cube system and associated software algorithms.

CathVision Secures 2.2 mEUR from Horizon 2020

Oct 31, 2019

CathVision ApS, a medical device company developing, manufacturing and selling cardiac electrophysiology products, has been awarded a competitive EU grant of 2.2M Euro for the clinical development of its software and clinical decision support platform.

CathVision Expands Board of DirectorsCathVision Expands Board of Directors

May 27, 2019

CathVision ApS, an early stage medical device company… announce today that the addition of two industry leaders to its Boards of Directors. Søren Thestrup-Nielsen MD, and Denis Gestin…

CathVision Raises Venture Funding to Market New EP Recording System

Jul 07, 2017

Medical device company CathVision has signed a multi-million venture investment from Scandinavian-based investors VF Venture and Borean Innovation.

Fon­de ka­ster mil­li­o­ner ef­ter hjer­te­for­stær­ker

Jul 07, 2017

Cathvision gør sig klar til at erobre et marked på 20 mia. kr. med en hjerteforstærker, der kan være på markedet inden for et par år

Hjerteforstærker får tocifret millioninvestering til ny behandling

Jul 07, 2017

Et nyt produkt skal sikre bedre behandling af hjerterytmeforstyrrelser. Det har sikret virksomheden CathVision en tocifret millioninvestering fra flere fonde.

Dansk hjertefirma rejser friske millioner

Jul 06, 2017

Et opstartsselskab, som står bag nyt innovativt hjerteudstyr, har rejst et tocifret millionbeløb fra to investorer. Pengene skal bruges til en tysk markedslancering.

CathVision Receives ISO 13485 Certification

Oct 02, 2018

CathVision ApS announced today that the company received ISO 13485:2016 certification for Medical Device and Quality Management Systems.

Danish start-up reaches important milestone in the EU

Oct 10, 2018

Danish medtech company Cathvision has received an iso-certification that paves the way for filing an application for CE approval in the EU next year.

Medicoopstart udvider til USA

May 11, 2018

Oprettelsen af et amerikansk datterselskab skal bane vejen til markedet for medicoselskabet CathVision, der forbereder studier og mulig produktion i landet.

CathVision: A Smoother Look at Cardiac Electrograms

Jul 07, 2017

CathVision is a Danish company that aims to reduce noisy electrogram signals during cardiac arrhythmia ablation procedures.

Hjerte-firma i små skridt mod milliardmarked

Aug 13, 2013

Hvad er der sket med de opfindsomme idéer, der blev belønnet med en Venture Cup-pris?